Supernus Pharmaceuticals, Inc.
SUPN
$32.47
$0.250.78%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 77.97% | 101.41% | 128.93% | 30.26% | -44.75% |
| Total Receivables | -1.44% | 2.57% | 11.67% | 2.90% | -12.90% |
| Inventory | -29.86% | -23.36% | -24.74% | -17.63% | -15.44% |
| Prepaid Expenses | 116.41% | 14.53% | -48.25% | 45.85% | 5.68% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 39.13% | 42.43% | 39.54% | -38.38% | -32.83% |
|
|
|||||
| Total Current Assets | 39.13% | 42.43% | 39.54% | -38.38% | -32.83% |
| Net Property, Plant & Equipment | -15.29% | -12.01% | -7.60% | -4.29% | -3.52% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -13.00% | -15.75% | -15.51% | -15.05% | -14.60% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -17.17% | -19.26% | -13.06% | -15.18% | -21.93% |
| Total Assets | 7.08% | 4.48% | 1.76% | -27.22% | -24.95% |
|
|
|||||
| Total Accounts Payable | 133.55% | 88.61% | 5.18% | 24.71% | -81.37% |
| Total Accrued Expenses | 8.39% | -1.63% | 9.94% | -2.56% | -10.45% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -17.31% | 8.81% | 20.75% | -97.79% | -97.99% |
| Total Finance Division Other Current Liabilities | -11.38% | 3.05% | 52.02% | 129.50% | 47.61% |
| Total Other Current Liabilities | -11.38% | 3.05% | 52.02% | 129.50% | 47.61% |
| Total Current Liabilities | 0.76% | 1.38% | 22.20% | -57.00% | -57.82% |
|
|
|||||
| Total Current Liabilities | 0.76% | 1.38% | 22.20% | -57.00% | -57.82% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -17.51% | -14.52% | -11.36% | -9.63% | -7.78% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -61.66% | -70.70% | -77.52% | -75.47% | -64.52% |
| Total Liabilities | -6.69% | -10.03% | -3.97% | -57.38% | -56.37% |
|
|
|||||
| Common Stock & APIC | 9.09% | 7.86% | 7.28% | 7.38% | 7.69% |
| Retained Earnings | 15.31% | 12.40% | 1.05% | -3.11% | 0.27% |
| Treasury Stock & Other | 68.13% | 106.47% | 79.04% | 77.07% | 81.53% |
| Total Common Equity | 12.39% | 10.41% | 4.08% | 1.87% | 3.98% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 12.39% | 10.41% | 4.08% | 1.87% | 3.98% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 12.39% | 10.41% | 4.08% | 1.87% | 3.98% |
|
|
|||||